MedPath
Found 539474 clinical trials
Sort by:

A Bioavailability Study of GS1-144 Tablets in Healthy Postmenopausal Women

Phase 1
Not yet recruiting
Conditions
Healthy Postmenopausal Women
Interventions
Drug: GS1-144 Tablet with new preparation (T)
Drug: GS1-144 Tablet with present preparation (R)
First Posted Date
2025-05-21
Last Posted Date
2025-05-21
Lead Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Target Recruit Count
24
Registration Number
NCT06983925
Locations
🇨🇳

Chengdu Xinhua Hospital, Chengdu, Sichuan, China

The Developmental Origins of Obesity

Not Applicable
Recruiting
Conditions
Maternal Obesity
Obesity
First Posted Date
2025-05-21
Last Posted Date
2025-05-21
Lead Sponsor
Pontificia Universidad Catolica de Chile
Target Recruit Count
160
Registration Number
NCT06981676
Locations
🇨🇱

Red Salud UC Christus Hospital, Santiago, Metropolitana, Chile

Early Recurrence of Renal Colic: Predictive Factors

Completed
Conditions
Renal Colic
Emergency Department Patient
First Posted Date
2025-05-21
Last Posted Date
2025-05-21
Lead Sponsor
University of Monastir
Target Recruit Count
878
Registration Number
NCT06982430
Locations
🇹🇳

Nouira Semir, Monastir, Tunisia

Supra Inguinal Fascia Iliaca Block as Rescue Analgesia Following Total Hip Arthroplasty

Not Applicable
Not yet recruiting
Conditions
Hip Arthroplasty, Total
Post Operative Pain, Acute
Nerve Block
First Posted Date
2025-05-21
Last Posted Date
2025-05-21
Lead Sponsor
Institut Mutualiste Montsouris
Target Recruit Count
310
Registration Number
NCT06982625

DIGITALIZATION OF PERSONALISED HEALTH RISK MANAGEMENT

Not Applicable
Recruiting
Conditions
Pre-obesity
Obesity
First Posted Date
2025-05-21
Last Posted Date
2025-05-21
Lead Sponsor
Slovak Academy of Sciences
Target Recruit Count
320
Registration Number
NCT06983431
Locations
🇸🇰

Center for Obesity Management EASO, Biomedical Research Center SAS, Bratislava, Slovakia

A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants

Phase 1
Not yet recruiting
Conditions
Overweight
Obesity
Interventions
Drug: Placebo
First Posted Date
2025-05-21
Last Posted Date
2025-05-21
Lead Sponsor
Hoffmann-La Roche
Target Recruit Count
40
Registration Number
NCT06982131

Randomized Trial Comparing Fecal Testing (FIT) to Colonoscopy for Post-polypectomy Surveillance

Not Applicable
Not yet recruiting
Conditions
Colorectal Neoplasms
First Posted Date
2025-05-21
Last Posted Date
2025-05-21
Lead Sponsor
Sorlandet Hospital HF
Target Recruit Count
4000
Registration Number
NCT06983639

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Phase 1
Not yet recruiting
Conditions
Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Breast Carcinoma
Metastatic Lung Non-Small Cell Carcinoma
Metastatic Malignant Neoplasm in the Bone
Metastatic Prostate Adenocarcinoma
Stage IV Lung Cancer AJCC v8
Stage IVB Prostate Cancer AJCC v8
First Posted Date
2025-05-21
Last Posted Date
2025-05-21
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
24
Registration Number
NCT06982222

Artificial Intelligence Based Models for Primary Sjögren's Syndrome Diagnosis

Completed
Conditions
Primary Sjögren's Syndrome (pSS)
First Posted Date
2025-05-21
Last Posted Date
2025-05-21
Lead Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Target Recruit Count
27432
Registration Number
NCT06982482
Locations
🇨🇳

Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China

EXACOS EG Population

Not yet recruiting
Conditions
Chronic Obstructive Pulmonary Disease
First Posted Date
2025-05-21
Last Posted Date
2025-05-21
Lead Sponsor
AstraZeneca
Target Recruit Count
240
Registration Number
NCT06983340
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy